| A Phase 1/2 Open-Label, Umbrella Platform Design of lnvestigational Agents With or Without Pembrolizumab (MK-3475) and/or Chemotherapy in Participants With Advanced Gastroesophageal Cancer: Master (KE |
Contract |
4,501,534.68 |
Clinical Trial |
Junaid Arshad |
Cancer Center Division |
11/2024 |
| A Phase 1b/2a, Double-Blind, Placebo-Controlled, Three Arm, Randomized Study Evaluating Continuous Infusion of LSTA1 Over 4 Hours When Added to Standard of Care (SoC) Versus a Single Intravenous (IV) |
Contract |
635,900.00 |
Clinical Trial |
Rachna Shroff |
Cancer Center Division |
11/2024 |
| A Phase Ib/III, Open-label, Randomised Study of Capivasertib plus CDK4/6 Inhibitors and Fulvestrant versus CDK4/6Inhibitors and Fulvestrant in Hormone Receptor-Positive and Human Epidermal Growth Fact |
Contract |
352,639.28 |
Clinical Trial |
Umbreen Rozell |
Cancer Center Division |
11/2024 |
| A Research Study to Advance the CF Therapeutics Pipeline for People without Modulators |
Contract |
77,007.00 |
Clinical Trial |
Cori Daines |
Asthma/Airway Disease Rsch Ctr |
11/2024 |
| A Two-Arm Randomized, Double-Blind, Placebo- Controlled Phase 2 Selection Trial to Evaluate the Efficacy and Safety of VB10.16 Alone or in Combination with Atezolizumab in Patients with HPV16-Positive |
Contract |
26,210.00 |
Clinical Trial |
Marina Miller |
Cancer Center Division |
11/2024 |
| An Open-Label Extension Study to Assess the Safety, Tolerability, and Effectiveness of the Long-Term Use of Treprostinil Palmitil Inhalation Powder in Participants with Pulmonary Arterial Hypertension |
Contract |
341,602.96 |
Clinical Trial |
Nafis Shamsid-Deen |
COM Phx Internal Medicine |
11/2024 |
| An Open-label Single-Arm Phase IIb Study of F901318 as Treatment of Invasive Fungal Infections Due to Lomentospora Prolificans, Scedosporium Spp., Aspergillus Spp., and Other Resistant Fungi in Patien |
Contract |
33,218.00 |
Clinical Trial |
Fariba Donovan |
Medicine |
11/2024 |
| Analysis of immunologic mechanisms in patients with chronic lung disease after acute COVID infection |
Grant |
540,280.00 |
Research |
Janko Nikolich |
Immunobiology |
11/2024 |
| Assessment of Long Term Endovascular AAA Intervention using the GORE EXCLUDER Conformable AAA Endoprosthesis or Iliac Branch Endoprosthesis |
Contract |
935,217.40 |
Clinical Trial |
Wei Zhou |
Surgery |
11/2024 |
| CFG-DermatologyFellowship-2024 |
Fellowship |
95,000.00 |
Research Training |
Daniel Butler |
Medicine |
11/2024 |
| Crisis Response - Trauma Informed Care Project |
Grant |
100,000.00 |
Other Sponsored Activity |
Jacy Farkas |
Family and Community Medicine |
11/2024 |
| Developing Tools to Study HPV16 in Oropharyngeal Tissues |
Grant |
152,596.00 |
Research |
Koenraad Van Doorslaer |
Immunobiology |
11/2024 |
| Development of a subcutaneous cell pharmacy implant |
Grant |
763,121.00 |
Research |
Klearchos Papas |
Surgery |
11/2024 |
| FCM COVID-19 Vaccine Study |
Contract |
95,537.00 |
Other Sponsored Activity |
Karen Lutrick |
Family and Community Medicine |
11/2024 |
| Inflammatory Bowel Disease West Case Conference |
Contract |
20,000.00 |
Instruction |
Sasha Taleban |
Medicine |
11/2024 |
| Inner Ear Ion Channels in Healthy and Diseased Conditions |
Grant |
2,127,419.00 |
Research |
Ebenezer Yamoah |
COM Phx Translational Neurosci |
11/2024 |
| Massive Transfusion in Children-2 |
Contract |
211,611.00 |
Research |
Louis Magnotti |
Surgery |
11/2024 |
| Prospective Evaluation of Cryoneurolysis of the Pudendal Nerve (PEC) |
Contract |
25,000.00 |
Clinical Trial |
Shamar Young |
Medical Imaging |
11/2024 |
| Serum Markers of Glucagon Sensitivity in Calorie Restricted Humans |
Grant |
425,958.00 |
Research |
Jennifer Stern |
Medicine |
11/2024 |
| Transspinal Magnetic Stimulation for the Treatment of Neuropathic Pain |
Grant |
578,902.00 |
Research |
Julie Pilitsis |
Neurosurgery |
11/2024 |
